V. Bichko

发表

Introduction of hepatitis delta virus into animal cell lines via cationic liposomes

J. Taylor, H. Netter, V. Bichko, 1994, Journal of virology.

Introduction ofHepatitis Delta Virus into AnimalCellLines viaCationic Liposomes

V. Bichko, A. Taylor, 1994 .

Novel protease and polymerase inhibiting agents to treat chronic hepatitis C infection

Tara L. Kieffer, A. Kwong, M. Tausek, 2008 .

Redistribution of the delta antigens in cells replicating the genome of hepatitis delta virus

J. Taylor, V. Bichko, 1996, Journal of virology.

Unique Properties of the Large Antigen of Hepatitis Delta Virus

R. Dunbrack, V. Bichko, Johnm . Taylor, 1999, Journal of Virology.

Hepatitis Delta Virus Unique Properties of the Large Antigen of

R. Dunbrack, V. Bichko, Johnm . Taylor, 1999 .

Expression of hepatitis B virus surface antigen gene in Escherichia coli.

G. Borisova, V. Bichko, E. Gren, 1984, Gene.

Phosphorylation of the hepatitis delta virus antigens

J. Taylor, S. Barik, V. Bichko, 1997, Journal of virology.

2′-C-Methyl Branched Pyrimidine Ribonucleoside Analogues: Potent Inhibitors of RNA Virus Replication

M. Tausek, S. Bergelson, V. Bichko, 2007, Antiviral chemistry & chemotherapy.

Synthesis and Antiviral Activity of Substituted Ethyl-2-Aminomethyl-5-Hydroxy-1H-Indole-3-Carboxylic Acids and Their Derivatives

Y. Ivanenkov, V. Bichko, I. Okun, 2015, Pharmaceutical Chemistry Journal.

The structure of cloned 3'-terminal RNA region of bovine leukemia virus (BLV).

V. Bichko, E. Gren, A. Tsimanis, 1983, Nucleic acids research.

The affinities of monoclonal antibodies against core antigen of hepatitis B virus

V. Bichko, U. Apsalons, 2005, Archives of Virology.

Immunochemical structure of the carboxy-terminal part of hepatitis B e antigen: identification of internal and surface-exposed sequences.

P. Pumpens, V. Bichko, B. Wahren, 1993, The Journal of general virology.

The Structure of the Variable Regions of Mouse Monoclonal Antibodies to Hepatitis B Virus Core Antigen

V. Bichko, E. Gren, A. Tsimanis, 1993, Scandinavian journal of immunology.

Epitopes recognized by antibodies to denatured core protein of hepatitis B virus.

G. Borisova, M. Nassal, V. Bichko, 1993, Molecular immunology.

Effect of Alpha Interferon on the Hepatitis C Virus Replicon

V. Bichko, C. Seeger, Ju-Tao Guo, 2001, Journal of Virology.

Subtype ayw variant of hepatitis B virus

V. Bichko, P. Pushko, E. Gren, 1985, FEBS letters.

NM 283 has potent antiviral activity against genotype 1 chronic hepatitis C virus (HCV-1) infection in the chimpanzee

M. Tausek, R. Chung, R. Lanford, 2003 .

Initiation of Hepatitis Delta Virus Genome Replication

K. Dingle, V. Bichko, Johnm . Taylor, 1998, Journal of Virology.

Differentiation of core gene products of the hepatitis B virus in infected liver tissue using monoclonal antibodies

H. Will, V. Bichko, N. Naoumov, 1997, Journal of medical virology.

Restriction map of the hepatitis B virus DNA cloned in Escherichia coli.

A. Janulaitis, V. Bichko, E. Gren, 1982, Gene.

Identification of hepatitis B virus core protein regions exposed or internalized at the surface of HBcAg particles by scanning with monoclonal antibodies.

P. Pumpens, B. Wahrén, G. Borisova, 1994, Virology.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

New Heterocyclic Hepatitis C Virus (HCV) Inhibitors Containing A 2-Aminomethyl-1H-Indole Fragment

V. Bichko, P. Yamanushkin, A. Ivachtchenko, 2015, Pharmaceutical Chemistry Journal.

Discovery of novel highly potent hepatitis C virus NS5A inhibitor (AV4025).

Y. Ivanenkov, M. Veselov, V. Bichko, 2014, Journal of medicinal chemistry.

Monoclonal antibodies against genetically manipulated hepatitis B core antigen.

V. Bichko, E. Korec, I. Hložánek, 1987, Folia biologica.

Novel oral anti-influenza drug candidate AV5080.

Y. Ivanenkov, M. Veselov, V. Bichko, 2014, The Journal of antimicrobial chemotherapy.

Pathogenesis associated with replication of hepatitis delta virus.

H. Netter, V. Bichko, T. Wu, 1994, Infectious agents and disease.

Tetrapeptide QDPR is a minimal immunodominant epitope within the preS2 domain of hepatitis B virus.

P. Pumpens, V. Bichko, P. Pushko, 1992, Immunology letters.

Novel oral anti-influenza prodrug candidate AV5075S.

Y. Ivanenkov, M. Veselov, V. Bichko, 2014, Journal of Antimicrobial Chemotherapy.

A novel influenza virus neuraminidase inhibitor AV5027.

Y. Ivanenkov, V. Bichko, O. Borisova, 2013, Antiviral research.

Hepatitis delta virus mutant: effect on RNA editing

J. Taylor, S. Lemon, V. Bichko, 1995, Journal of virology.

RNA editing in the replication cycle of human hepatitis delta virus.

J. Taylor, H. Netter, V. Bichko, 1994, Biochimie.

Synthesis and Antiviral Activity of Substituted Ethyl-2-Aminomethyl-5-Hydroxy-1H-Indole-3-Carboxylic Acids and Their Derivatives

Y. Ivanenkov, V. Bichko, I. Okun, 2015, Pharmaceutical Chemistry Journal.

Epitopes exposed on hepatitis delta virus ribonucleoproteins

J. Taylor, S. Lemon, M. Lai, 1996, Journal of virology.

Electrophoretic analysis of the ribonucleoproteins of hepatitis delta virus.

J. Taylor, K. Dingle, V. Bichko, 1998, Journal of virological methods.

A novel form of hepatitis delta antigen

J. Taylor, Y. Khudyakov, V. Bichko, 1996, Journal of virology.